The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNEL.L Regulatory News (CNEL)

  • There is currently no data for CNEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

28 Sep 2015 07:00

RNS Number : 2995A
China New Energy Ltd
28 September 2015
 



28 September 2015

 

China New Energy Limited

("China New Energy" "CNE" or "the Group")

 

 

Half-yearly report for the six months to 30 June 2015

 

China New Energy Limited (AIM: CNEL), an engineering and technology solutions provider to the bioenergy sector, announces its unaudited half-yearly results for the six months ended 30 June 2015.

 

Financial Highlights

· Revenue of RMB 26.7m (H1 2014: RMB 16.4m)

· Gross profit of RMB 3.06m (H1 2014: RMB 2.98m)

· Net loss of RMB 5.54m (H1 2014: loss of RMB 4.55m)

· Loss per share of RMB 0.014 (H1 2014: RMB 0.014)

 

 

Yu Weijun, Chairman, commented:

 

"As previously commented, historically we usually make a loss in the first half of the year as most projects are completed and paid for in the second half of the year. For the remainder of this financial year, we will focus on biofuel development in developing countries and hope to secure new international contracts.

 

Looking ahead, we remain confident that low-carbon biofuel will be a clear alternative to fossil fuel and growth will return to the bioenergy sector. We continue to look to the long-term future with confidence."

 

Enquiries:

 

China New Energy Limited

www.chinanewenergy.co.uk

Richard Bennett

Tel: +44 (0)20 7148 3148 or rbennett@zkty.com.cn

Ivy Xu

Tel: +86 (0)20 8705 9371 or xuhj@zkty.com.cn

 

 

Cairn Financial Advisers LLP (NOMAD)

Tel: +44 20 7148 7900

Jo Turner / Liam Murray

 

 

 

Daniel Stewart and Co (Broker)

Tel: +44 20 7776 6550

Martin Lampshire / David Coffman

 

 

 

 

Chairman's Statement

 

On behalf of the Board, I am very pleased to present the unaudited half-yearly results for the six month period ended 30 June 2015.

 

Financial Review

 

Revenue for the first six months of the year was up to RMB 26.7m (H1 2014:RMB 16.4m) and the Group's gross profit increased to RMB 3.06m (H1 2014:RMB 2.98m). The net loss for the period under review was RMB 5.5m (H1 2014: RMB 4.5m). Due to the cyclical nature of our business, we usually make a loss in the first half of the year as most projects are completed and paid for in the second half of the year.

 

The first half of the year was challenging for the Group's core Equipment, Procurement and Construction ("EPC") business. This is mainly due to the continued depressed ethanol price and lower demand for ethanol related products during the period, which in-turn continues to delay the capital expenditure of ethanol producers.

 

Selling and distribution expenses increased by 63.0% to RMB 2.25m (H1 2014:RMB 1.38m) while administrative expenses decreased by 11.4% to RMB 4.63m (H1 2014:RMB 5.22m). The Group's other operating expenses increased to RMB 1.26m (H1 2014:RMB 0.76m). Finance expense increased by to RMB 0.51m (H1 2014:RMB 0.22m) due to short term borrowing debt, but as of the end of June, the borrowing was repaid to the bank.

 

 

Operational Review

The Group principally provides EPC services and Value Added Services ("VAS") to ethanol and biobutanol producers. The EPC team primarily design and build commercial-scale biorefineries that convert feedstock into ethanol for both the biofuel and edible alcohol markets, whilst the VAS team provide services and technology to optimise the ethanol production at existing biorefineries.

 

CNE is a market leader in China at designing and building 1st Generation biorefineries that convert agricultural feedstock such as corn, cassava and sugarcane into ethanol. We have completed more than 100 1st Generation projects in China and around the world.

 

The market is evolving as our customers in developed nations seek to use cellulosic (non-food) feedstock such as corn stover and municipal waste in 2nd Generation biorefineries. It remains a priority for CNE to commercialise the 2nd Generation technology, as we believe this will stimulate demand for building new biorefineries in China and around the world.

 

In H1 2015, the Group secured several contracts for its products and services in China and Southeast Asia. The total contracted amount for the period was RMB 41.98m (H1 2014:RMB 49.57 million), 15.3% lower than the same period in 2014. During the period, CNE acquired a 24% stake in the Visontai Bioetanol Fejlesztő Korlátolt Felelősségű Társaság ("Visontai") bioenergy project that is being developing by Hungarian partners in Hungary.

 

We also continue to focus on our sales pipeline of EPC contracts, particular in South East Asia and Sub-Saharan Africa. CNE had signed a MOU with UBE who wanted to develop the second project in Thailand. To meet local environmental legislation, UBE is currently conducting an Environmental Impact Assessment ("EIA") for the new project and the influence of the lower oil price. CNE is waiting for the project to commence.

 

In Sub-Saharan Africa, CNE entered into a development partnership with Sunbird Bioenergy Africa ("Sunbird") in 2013 with the intention of developing an initial 120 million litre per year cassava-to-ethanol biorefinery in Nigeria with an additional 9 projects forecast across the region. In Nigeria, Sunbird and the local development partner OBAX World Wide Limited ("OBAX") reported that they have completed the land and agricultural survey and crop enumeration of the 20,000 Ha of land for the project and are awaiting the final certificate of occupancy from the Ministry of Agriculture and Rural Development. Sunbird and OBAX have met the conditions needed for the certificate of occupancy and expect it to be granted imminently. CNE reviewed Sunbird's project pipeline for the region and met with key stakeholders in Zambia and Zimbabwe. As in Thailand, employment and energy security were identified as the key drivers for bioenergy projects in the region. Sunbird has been awarded an investment license by the Zambian Development Agency for US$150 million to build a cassava to ethanol biorefinery and cassava plantation. CNE is optimistic about tendering for a part of this business in due course.

 

 

Outlook

 

After the recent turmoil in the global financial markets and the bioethanol market downturn, there is a risk that the Group may continue to face difficult trading conditions and as a result the Board maintains its cautious business approach. Nevertheless, the Board remains positive about the Group's prospects and outlook in the biofuel industry.

 

China is an important participant in global energy markets. In the interests of its energy security, the PRC government has enacted various laws and regulations encouraging the use of renewable energy as a substitute for fossil fuels. Bioenergy is widely considered to be one of the key alternatives to fossil fuel use because of its easy acquisition and cleaner emissions. Our strategy is to craft core competence in the provision of a full spectrum of engineering technology for the renewable fuel and chemicals sector. We strive to provide superior technology and engineering solutions from feedstock conversion to end waste management for the bioenergy and biochemical sectors, enabling producers in these sectors to achieve environmentally friendlier products with improving operating margins.

 

The global recession, especially in the U.S. and Europe, may further impede the available resources for research and development activities in our industry. The Group, however, intends to continue to channel its own resources into biofuel production research and development by relying on our qualified staff and by collaborating with external institutions to carry out further research and development activities. Our collaboration partners include Guangzhou Institute of Energy Conversion ("GIEC"), part of the Chinese Academy of Sciences. GIEC is a leading research institute in the PRC that specialises in the research of alternative and renewable energy technologies. We believe our close long term working relationship with GIEC can help to commercialise our R&D much faster and at a lower cost.

 

While the Board maintains its cautious approach in view of the current global macro-economic conditions and a slowdown in demand for ethanol, the Directors and management team are optimistic for the Group's long-term outlook and are determined to position the Group for growth. The Group also continues to explore opportunities and negotiate new projects in the PRC and overseas with prospective customers. To strengthen our market position and to add value to our existing business, the Group is also actively exploring opportunities to expand into complementary businesses or operations through acquisitions, joint ventures or strategic alliances.

 

 

 

Yu Weijun

Chairman

Consolidated Statement of Financial Position

 

 

Unaudited

 

Unaudited

 

Audited

As at

30 June

 

As at

30 June

 

As at

31 December

 

 

2015

 

2014

 

2014

 

Note

RMB'000

 

RMB'000

 

RMB'000

Non-current assets

 

 

 

 

 

 

Property, plant and equipment

3

6,995

 

10,582

 

7,900

Intangible assets

4

9,589

 

6,500

 

8,138

Trade receivables

 

3,523

 

3,523

 

3,523

Investments in subsidiaries

 

-

 

150

 

-

 

 

20,107

 

20,755

 

19,561

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Inventories

 

14,929

 

22,313

 

11,841

Due from customers for construction contracts

 

34,842

 

45,676

 

38,075

Trade and other receivables

 

58,412

 

44,495

 

44,667

Notes receivables

 

410

 

1,940

 

500

Cash and cash equivalents

 

13,802

 

15,053

 

14,875

 

 

122,395

 

129,477

 

109,958

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

90,774

 

91,713

 

77,452

Due to customers for construction contracts

 

25,432

 

20,077

 

14,040

Notes payable

 

-

 

3,000

 

-

Income tax payable

 

9,208

 

8,825

 

8,776

Short-term borrowing

 

-

 

6,600

 

6,600

 

 

125,414

 

130,215

 

106,868

 

 

 

 

 

 

 

Net current assets/(liabilities)

 

(3,019)

 

(738)

 

3,090

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

Deferred tax liabilities

 

815

 

815

 

815

 

 

815

 

815

 

815

 

 

 

 

 

 

 

Net assets

 

16,273

 

19,202

 

21,836

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share Capital

2

1,325

 

1,214

 

1,325

Share premium

 

54,925

 

49,118

 

54,925

Combination reserve

 

(33,156)

 

(33,156)

 

(33,156)

Warrants reserve

 

1,673

 

1,673

 

1,673

Statutory reserve

 

12,328

 

12,328

 

12,328

Own shares

 

-

 

(5,853)

 

-

Accumulated earnings/(losses)

 

(44,438)

 

(29,239)

 

(38,895)

Foreign currency translation reserve

 

23,616

 

23,117

 

23,636

Total

 

16,273

 

19,202

 

21,836

 

 

 

Consolidated Statement of Comprehensive Income

 

 

 

Unaudited

 

Unaudited

 

Audited

Six months to 30 June 2015

 

Six months to 30 June 2014

 

Year to 31 December 2014

 

Note

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

 

 

Revenue

 

26,671

 

16,392

 

57,309

Cost of sales

 

(23,609)

 

(13,409)

 

(53,010)

 

 

 

 

 

 

 

Gross profit/(loss)

 

3,062

 

2,983

 

4,299

 

 

 

 

 

 

 

Other operating income

 

53

 

63

 

323

Selling and distribution expenses

 

(2,252)

 

(1,382)

 

(3,200)

Administrative expenses

 

(4,629)

 

(5,224)

 

(11,517)

Other operating expenses

 

(1,263)

 

(757)

 

(1,857)

Finance expenses

 

(512)

 

(222)

 

(791)

Bad debt provision(net)

 

-

 

-

 

6,970

Impairment loss

 

-

 

-

 

(2,681)

 

 

 

 

 

 

 

(Loss)/ Profit before income tax

 

 

 

 

 

 

(5,541)

 

(4,539)

 

(8,454)

Income tax expense

 

-

 

(10)

 

(10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss)/Profit for the financial period

 

(5,541)

 

(4,549)

 

(8,464)

 

 

 

 

 

 

 

Other comprehensive income:

 

 

 

 

 

 

Exchange difference

 

(21)

 

(424)

 

207

 

 

(5,562)

 

(4,973)

 

(8,257)

Total comprehensive income for the financial year

 

 

 

 

(5,562)

 

(4,973)

 

(8,257)

Total comprehensive income attributable to equity holder

 

 

 

 

 

 

 

 

 

Earnings/(loss) per share (RMB):

 

 

 

 

 

 

Basic

5

(0.014)

 

(0.014)

 

(0.023)

Diluted

5

(0.014)

 

(0.015)

 

(0.023)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Statement of Cash flows

 

 

 

Unaudited

 

Unaudited

 

Audited

Six months to 30 June

 

Six months to 30 June

 

Year to 31 December

 

 

2015

 

2014

 

2014

 

 

RMB'000

 

RMB'000

 

RMB'000

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

Profit/(loss) before income tax

 

(5,541)

 

(4,549)

 

(8,454)

Adjustments for:

 

 

 

 

 

 

Depreciation and amortisation

 

1,688

 

1,274

 

2,619

 

Bad debt provision(net)

 

-

 

-

 

(6,970)

Loss/(gain) on disposal of property, plant and equipment

 

-

 

-

 

2

 

 

 

 

 

 

 

Interest income

 

(25)

 

(24)

 

(92)

Finance expense

 

537

 

266

 

791

Impairment loss

 

-

 

-

 

2,681

Exchange difference

 

-

 

-

 

207

Operating cash flows before movements in working capital

 

 

 

(3,341)

 

(3,033)

 

(9,216)

 

 

 

 

 

 

 

Decrease/(increase) in inventories

 

(3,088)

 

(6,615)

 

2,826

Construction work-in-progress

 

14,625

 

7,503

 

10,283

Trade and other receivables

 

(13,745)

 

(2,225)

 

(9,125)

Notes receivables

 

90

 

(940)

 

-

Trade and other payables

 

13,754

 

3,011

 

2,529

Decrease/(increase) in due to

customers for construction

 

-

 

3,000

 

(809)

 

Cash generated from/(used in) operations

 

 

8,295

 

 

701

 

 

(3,512)

Income taxes paid

 

-

 

(10)

 

(10)

Net cash from/(used in) operating activities

 

8,295

 

691

 

(3,522)

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Purchase of property, plant and equipment

 

(158)

 

(8)

 

(71)

Expenditure on intangible assets

 

 

(2,076)

 

(209)

 

(1,949)

 

Net cash from/(used in) investing activities

(2,234)

 

(217)

 

(2,020)

 

 

 

 

 

Financing activities

 

 

 

 

 

Short-term borrowing

-

 

-

 

6,600

Repayment of borrowings

(6,600)

 

-

 

(6,600)

Proceeds from issuance of shares

 -

 

 -

 

5,918

Redemption of convertible bonds

 -

 

 -

 

-

Interest received

24

 

 24

 

92

Interest paid

 

(537)

 

(220)

 

(791)

 

 

 

 

 

 

Net cash from/(used in) financing activities

(7,113)

 

(196)

 

(5,219)

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

(1,052)

 

278

 

(323)

Cash and bank balances at beginning of period

14,875

 

15,198

 

15,198

Effect of foreign exchange rate changes in cash and bank balances

(21)

 

(423)

 

-

Cash and cash equivalents at end of period

13,802

 

15,053

 

14,875

 

 

 

 

Consolidated Statement of Changes in Equity

 

 

Share capital

 

Share premium

 

Combination

 

Statutory reserve

 

Convertible bonds reserve

 

Warrants reserve

 

Own shares

 

Accumulated earnings/ (losses)

 

Foreign currency translation reserve

 

Total

 
 

 

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

RMB'000

 

Balance at 31 December 2013

 

1,214

 

49,118

 

(33,156)

 

12,328

 

-

 

1,673

 

(5,853)

 

(24,690)

 

23,541

 

24,175

 

Profit for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(8,464)

 

-

 

(8,464)

 

Exchange difference arising on the translation

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

207

 

207

 

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(8,464)

 

207

 

(8,257)

 

Issue of shares, net of share issue costs

 

111

 

5,807

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

5,918

 

Shares granted to

Cancellation of EBT

 

-

 

-

 

-

 

-

 

-

 

-

 

5,853

 

(5,741)

 

(112)

 

-

 

Balance at 31 December 2014

 

1,325

 

54,925

 

(33,156)

 

12,328

 

 

 

1,673

 

 

 

(38,895)

 

23,636

 

21,836

 

Profit for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(5,542)

 

-

 

(5,542)

 

Exchange difference arising on the translation

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(20)

 

(20)

 

Total comprehensive income for the period

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(5,542)

 

(20)

 

(5,562)

 

Issue of warrants

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

Issue of shares, net of share issue costs

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

Transfer to statutory reserve

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

Balance at 30 June 2015

 

1,325

 

54,925

 

(33,156)

 

12,328

 

-

 

1,673

 

-

 

(44,438)

 

23,616

 

16,273

 

 

 

 

Notes to the Interim Financial Information - Period ended 30 June 2015

 

1. Basis of preparation

 

The financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union. The principal accounting policies used in preparing the interim results are those the group expects to apply in its financial statements for the year ending 31 December 2015 and are unchanged from those disclosed in the group's Report and Financial Statements for the year ended 31 December 2014, except for the following additional accounting policies:

 

Basis of consolidation

The Group includes the assets and liabilities of the Employee Benefit Trust ("EBT") within its Statement of Financial Position. In the event of the winding up of the Group, neither the shareholders nor the creditors would be entitled to the assets of the EBT.

 

Long-term incentive scheme charge

The fair value of the employee services received in exchange for the grant of shares or share options is recognised as an expense.

 

The total amount to be expensed over the performance period, from grant date to vesting date, is determined by reference to the fair value of the shares determined at the date the employee is deemed to be fully aware of their potential entitlement and all conditions of vesting.

 

Own shares

Company shares held by the EBT are deducted from the shareholders' funds and classified as Own Shares until such time as they vest unconditionally to participating employees and their families.

 

This interim financial information has not been reviewed or audited by the Group's auditors. The comparatives for the period ended 31 December 2014 are not the Group's full statutory accounts for that period but have been extracted from those financial statements. A copy of the statutory financial statements for that period, which were prepared under IFRS, has been delivered to the Companies Registry. The auditors' report on those accounts was unqualified.

 

Whilst the financial information included in this Interim Financial information has been prepared in accordance with the recognition and measurement criteria of IFRS, it does not include sufficient information to comply with IFRS.

 

This interim report was approved by the Board of directors on 28 September 2015.

 

 

2. Ordinary shares

 

 

 

 Number of Shares

 Share Capital

 Share premium

 

 

 £ '000

 RMB '000

 £ '000

 RMB '000

As at 31st December 2010

6,733,107

67

1,013

1,952

29,354

As at 21st March 2011

67,331,070

67

1,013

1,952

29,354

As at 6 May 2011

269,324,280

67

1,013

1,952

29,354

 

 

 

 

 

 

Shares issued in connection with the Placing

9,360,147

2

24

653

6,756

Share issued in settlement of fees to professional

9,920,295

2

26

692

7,160

Share issued to EES Trustees International Limited

8,079,728

2

21

564

5,832

Shares issued to Citadel pursuant to warrant agreement

7,932,412

2

20

305

3,152

Placing on 14 Dec 2011

6,000,000

2

14

258

2,650

Less share issue costs

-

-

-

-

(16,303)

As at 31 December 2011

310,616,862

-

1,118

-

38,601

 

 

 

 

 

 

Placing on 25 Sept 2012

6,000,000

2

15

59

601

Less share issue costs

-

-

-

(3)

(31)

As at 31 December 2012

316,616,862

-

1,133

-

39,171

As at 30 June 2013

316,616,862

-

1,133

-

39,171

Placing on 4 Nov 2013

10,000,000

3

24

248

2,425

Less share issue costs

-

-

-

(17)

(171)

 

 

 

 

 

 

Placing on 25 Nov 2013

8,571,429

2

21

298

2,966

Less share issue costs

-

-

-

(21)

(209)

Placing on 26 Nov 2013

6,666,667

2

17

248

2,462

 

 

 

 

 

 

Placing on 29 Nov 2013

7,107,143

2

18

246

2,474

 

 

 

 

 

 

As at 31 December 2013

348,962,101

-

1,214

-

49,118

Placing on 29 Sept 2014

44,652,107

11

111

584

5,807

As at 31 December 2014

393,614,208

-

1,325

-

54,925

As at 30 June 2015

393,614,208

-

1,325

-

54,925

 

 

 

The substantial shareholders have not changed from 31 December 2014. The Group has one class of ordinary shares which carry no right to fixed income.

 

 

3. Property, plant and equipment

 

 

 

Plant and machinery

Motor Vehicles

Office equipment

Leasehold improvements

Total

 

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

 

Cost

 

 

 

 

 

 

 

At 1 January 2015

 

4,226

8,865

672

6,247

20,010

Additions

 

-

-

158

-

158

Disposals

 

-

-

-

-

-

 

 

 

 

 

 

 

At 30 June 2015

 

4,226

8,865

830

6,247

20,168

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

At 1 January 2015

 

2,464

5,649

442

3,555

12,110

Charged for the year

 

349

622

86

6

1,063

Disposals

 

-

-

-

-

-

 

 

 

 

 

 

 

At 30 June 2015

 

2,813

6,271

528

3,561

13,173

 

 

Carrying amount

 

 

 

 

 

 

At 1 January 2015

 

1,762

3,216

230

2,692

7,900

 

 

 

 

 

 

 

At 30 June 2015

 

1,413

2,594

302

2,686

6,995

 

 

 

 

 

 

4. Intangible assets

 

 

Computer software

Patents

Land management

Development cost

Total

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

 

 

 

 

 

 

Cost

 

 

 

 

 

At 1 January 2015

60

1,283

3,613

4,208

9,164

Additions

-

132

-

1,944

2,076

Transfer

-

-

-

-

-

Balance at end of year

60

1,415

3,613

6,152

11,240

 

 

 

 

 

 

Accumulated amortisation

 

 

 

 

 

At 1 January 2015

45

305

676

-

1,026

Amortisation for the year

3

79

235

308

625

Balance at end of year

48

384

911

308

1,651

 

Carrying amount

 

 

 

 

 

 

At 1 January 2015

15

978

2,937

4,208

8,138

 

 

 

 

 

 

At 30 June 2015

12

1,031

2,702

5,844

9,589

 

 

5. Earnings per share

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings

Weighted average number of shares

Earning per shares

Earnings

Weighted average number of shares

Earning per shares

 

Six months

Six months

Six months

Six months

Six months

Six months

 

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

 

2015

2015

2015

2014

2014

2014

 

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

 

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Earnings/(loss)per share-basic

(5,562)

393,614,208

(0.014)

(4,973)

348,962,101

(0.014)

Potentially dilutive shares

-

-

-

-

 

-

Earnings/(loss)per share-diluted

(5,562)

393,614,208

(0.014)

(4,973)

348,962,101

(0.014)

 

 

 

6. Directors' interests

 

The following Directors have held office during the period and their interests as at 30 June 2015, all of which are beneficial unless otherwise stated, whether direct or indirect, of the Directors and their families in the issued share capital of the company and options over Ordinary Shares which had been granted, are as follows:

 

Director

 

Number of Ordinary Shares

 

Percentage of Ordinary Shares

Yu Weijun

 

90,932,440

 

23.10%

Tang Zhaoxing

 

48,000,000

 

12.19%

Richard Bennett

 

-

 

-

 

7. Business Segment

 

The CNE Group's assets, liabilities and capital expenditure are almost entirely attributable to a single business segment of provision of technology and engineering services to ethanol, ethanol downstream product and biobutanol producers. Therefore, the CNE Group does not have separately reportable business segments under IFRS 8 Segmental Reporting. Nonetheless the CNE Group's revenue and results can be classified into the following streams:

 

a. EPC of plants producing ethanol and ethanol downstream products ("EPC activities"); and

b. Value-added and other value added services ("VAS") services.

 

 

 

 

 

 

 

 

 

 

EPC

 

VAS

 

Total

Revenue

 

RMB'000

 

RMB'000

 

RMB'000

Unaudited six months to 30 Jun 2015

 

26,512

 

159

 

26,671

Unaudited six months to 30 Jun 2014

 

15,605

 

787

 

16,392

Year ended 31 Dec 2014

 

56,690

 

619

 

57,309

Gross Profit

 

 

 

 

 

 

Unaudited six months to 30 Jun 2015

 

3,032

 

30

 

3,062

Unaudited six months to 30 Jun 2014

 

2,357

 

626

 

2,983

Year ended 31 Dec 2014

 

4,093

 

206

 

4,299

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUUCBUPAGQA
Date   Source Headline
14th Jul 20206:00 pmRNSChina New Energy
14th Jul 20204:49 pmRNSHKEx Admission and Cancellation of Trading on AIM
14th Jul 20202:05 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:06 amRNSSecond Price Monitoring Extn
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSGlobal Offering, Issue of Equity and HKEx update
30th Jun 20207:00 amRNSPublication of Prospectus and Global Offering
29th Jun 20204:40 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSHong Kong Listing Update
8th Jun 202011:05 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:08 pmRNSConvertible Loan Extension
16th Apr 202010:31 amRNSResult of AGM
30th Mar 202011:56 amRNSResubmission of Hong Kong Listing Application
26th Mar 20201:53 pmRNSPosting of Circular and Notice of AGM
26th Mar 202012:56 pmRNSFinal Results
11th Feb 20207:00 amRNSTrading Update and Coronavirus Information
4th Feb 20202:05 pmRNSSecond Price Monitoring Extn
4th Feb 20202:00 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSHong Kong Listing Update
24th Oct 20198:36 amRNSDirector/PDMR Shareholding
23rd Oct 201910:35 amRNSResult of EGM
15th Oct 20192:05 pmRNSSecond Price Monitoring Extn
15th Oct 20192:00 pmRNSPrice Monitoring Extension
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:28 pmRNSPosting of Circular and Notice of EGM
27th Sep 20193:45 pmRNSHalf-year Report
5th Sep 20192:05 pmRNSSecond Price Monitoring Extn
5th Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 20194:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20194:36 pmRNSPrice Monitoring Extension
29th Jul 201910:13 amRNSResult of AGM
26th Jul 20192:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20194:11 pmRNSHolding(s) in Company
23rd Jul 20193:31 pmRNSHolding(s) in Company
22nd Jul 201911:20 amRNSDirector/PDMR Shareholding
28th Jun 20198:31 amRNSNotice of AGM
25th Jun 20197:00 amRNSUpdate re Listing
19th Jun 20195:59 pmRNSFinal Results
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
15th Mar 20197:00 amRNSDirector's Dealing
21st Feb 20197:00 amRNSAppointment of Broker
8th Feb 20199:05 amRNSSecond Price Monitoring Extn
8th Feb 20199:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSConvertible Loan Agreement
17th Dec 20184:39 pmRNSTrading Update
24th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.